Literature DB >> 15648005

Effects of hemodialysis on protein metabolism.

T Alp Ikizler1.   

Abstract

Uremic malnutrition, as evidenced by decreased muscle mass, is strongly associated with increased risk of death and hospitalization events in chronic hemodialysis (CHD) patients. Several factors that influence protein metabolism predispose CHD patients to increased catabolism and loss of lean body mass. It has been long suspected that the hemodialysis (HD) procedure is a net catabolic event. Recent studies show that the HD procedure indeed induces a net protein catabolic state at the whole-body level as well as in skeletal muscle. There is evidence to suggest that these undesirable effects are caused by decreased protein synthesis and increased proteolysis. Animal studies suggest that decreased protein synthesis is likely mediated by the significant decrease in plasma amino acid concentrations during HD. On the other hand, increased protein degradation is, at least in part, mediated by the HD-associated inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15648005     DOI: 10.1053/j.jrn.2004.09.019

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  9 in total

1.  Dietary egg whites for phosphorus control in maintenance haemodialysis patients: a pilot study.

Authors:  Lynn M Taylor; Kamyar Kalantar-Zadeh; Theodore Markewich; Sara Colman; Debbie Benner; John J Sim; Csaba P Kovesdy
Journal:  J Ren Care       Date:  2011-03

2.  Nutritional status after conversion from conventional to in-centre nocturnal hemodialysis.

Authors:  Nazanin Noori; Andrew T Yan; Mercedeh Kiaii; Andrea Rathe; Marc B Goldstein; Olugbenga Bello; Ron Wald
Journal:  Int Urol Nephrol       Date:  2017-04-29       Impact factor: 2.370

3.  Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial.

Authors:  Manoch Rattanasompattikul; Miklos Z Molnar; Martin L Lee; Ramanath Dukkipati; Rachelle Bross; Jennie Jing; Youngmee Kim; Anne C Voss; Debbie Benner; Usama Feroze; Iain C Macdougall; John A Tayek; Keith C Norris; Joel D Kopple; Mark Unruh; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-09-20       Impact factor: 12.910

Review 4.  Diets and enteral supplements for improving outcomes in chronic kidney disease.

Authors:  Kamyar Kalantar-Zadeh; Noël J Cano; Klemens Budde; Charles Chazot; Csaba P Kovesdy; Robert H Mak; Rajnish Mehrotra; Dominic S Raj; Ashwini R Sehgal; Peter Stenvinkel; T Alp Ikizler
Journal:  Nat Rev Nephrol       Date:  2011-05-31       Impact factor: 28.314

Review 5.  Regulation of muscle protein synthesis and the effects of catabolic states.

Authors:  Bradley S Gordon; Andrew R Kelleher; Scot R Kimball
Journal:  Int J Biochem Cell Biol       Date:  2013-06-12       Impact factor: 5.085

6.  Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?

Authors:  Christian S Shinaberger; Sander Greenland; Joel D Kopple; David Van Wyck; Rajnish Mehrotra; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Am J Clin Nutr       Date:  2008-12       Impact factor: 7.045

Review 7.  A practical approach to the nutritional management of chronic kidney disease patients in Cape Town, South Africa.

Authors:  Oluwatoyin I Ameh; Lynette Cilliers; Ikechi G Okpechi
Journal:  BMC Nephrol       Date:  2016-07-08       Impact factor: 2.388

8.  Steady exercise improves hand grip and leg muscle strength in hemodialysis patients.

Authors:  Ran-Hui Cha; Geum Sil Lee
Journal:  J Exerc Rehabil       Date:  2021-12-27

9.  Comparison of intradialytic neuromuscular electrical stimulation and oral nutritional supplements in hemodialysis patients: study protocol for a multicenter, parallel-group, randomized controlled trial in Korea.

Authors:  Mi-Yeon Yu; Jae Hyeon Park; Yong Chul Kim; Jae Yoon Park; Ran-Hui Cha
Journal:  Trials       Date:  2021-12-20       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.